Cargando…

Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells

Successful chemotherapeutic intervention for management of lung cancer requires an efficient drug delivery system. Gold nanoparticles (GNPs) can incorporate various therapeutics; however, GNPs have limitations as drug carriers. Nano-sized cellular vesicles like exosomes (Exo) can ferry GNP-therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srivastava, Akhil, Amreddy, Narsireddy, Babu, Anish, Panneerselvam, Janani, Mehta, Meghna, Muralidharan, Ranganayaki, Chen, Allshine, Zhao, Yan Daniel, Razaq, Mohammad, Riedinger, Natascha, Kim, Hogyoung, Liu, Shaorong, Wu, Si, Abdel-Mageed, Asim B., Munshi, Anupama, Ramesh, Rajagopal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5150529/ https://www.ncbi.nlm.nih.gov/pubmed/27941871 http://dx.doi.org/10.1038/srep38541

Ejemplares similares

Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment
por: Amreddy, Narsireddy, et al.
Publicado: (2017)

Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration
por: Muralidharan, Ranganayaki, et al.
Publicado: (2016)

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
por: Babu, Anish, et al.
Publicado: (2017)

Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
por: Amreddy, Narsireddy, et al.
Publicado: (2015)

HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration, and invasion in lung cancer
por: Muralidharan, Ranganayaki, et al.
Publicado: (2015)

Progress in extracellular vesicle biology and their application in cancer medicine
por: Srivastava, Akhil, et al.
Publicado: (2020)

HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy
por: Mehta, Meghna, et al.
Publicado: (2016)

IL-24 Inhibits Lung Cancer Growth by Suppressing GLI1 and Inducing DNA Damage
por: Panneerselvam, Janani, et al.
Publicado: (2019)

IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells
por: Panneerselvam, Janani, et al.
Publicado: (2016)

HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells
por: Muralidharan, Ranganayaki, et al.
Publicado: (2017)

Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity
por: Panneerselvam, Janani, et al.
Publicado: (2015)

Molecular targets and signaling pathways regulated by interleukin (IL)-24 in mediating its antitumor activities
por: Panneerselvam, Janani, et al.
Publicado: (2013)

Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells
por: Ahmed, Rebaz, et al.
Publicado: (2021)

YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways
por: Andrade, Daniel, et al.
Publicado: (2017)

Pharmacokinetics of Nanosomal Form of Levodopa in Intranasal Administration
por: Nedorubov, Andrey Anatolievich, et al.
Publicado: (2019)

Novel Nanosomes for Gene Delivery to Plasmodium falciparum-infected Red Blood Cells
por: Gopalakrishnan, Anusha M., et al.
Publicado: (2013)

Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
por: Hsiao, Yai-Ping, et al.
Publicado: (2020)

Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
por: Narsireddy, Amreddy, et al.
Publicado: (2015)

Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy
por: Srivastava, Akhil, et al.
Publicado: (2021)

HuR Reduces Radiation-Induced DNA Damage by Enhancing Expression of ARID1A
por: Andrade, Daniel, et al.
Publicado: (2019)

Nanosomal docetaxel lipid suspension based chemotherapy in a pregnant MBC patient – a case report
por: Ramaswamy, Rajkumar, et al.
Publicado: (2019)

Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study
por: Narayanan, Prasad, et al.
Publicado: (2019)

Estradiol-ERβ2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion
por: Kim, Hogyoung, et al.
Publicado: (2016)

Noninvasive visualization of early osteoarthritic cartilage using targeted nanosomes in a destabilization of the medial meniscus mouse model
por: Cho, Hongsik, et al.
Publicado: (2018)

Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study
por: Subramanian, Sundaram, et al.
Publicado: (2020)

Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8(+)T Cell Immunity
por: Domvri, Kalliopi, et al.
Publicado: (2022)

Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells
por: Khurana, Namrata, et al.
Publicado: (2020)

A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate Cancer
por: Samar, Aseem, et al.
Publicado: (2020)

Management of primary squamous cell carcinoma of the pancreas with a nanosomal paclitaxel lipid suspension-based regimen: A case report
por: Kumar Das Majumdar, Saroj, et al.
Publicado: (2019)

Latent HIV-Exosomes Induce Mitochondrial Hyperfusion Due to Loss of Phosphorylated Dynamin-Related Protein 1 in Brain Endothelium
por: Chandra, Partha K., et al.
Publicado: (2021)

Efficacy and safety of nanosomal docetaxel lipid suspension-based chemotherapy in squamous cell carcinoma of the head and neck: A multicenter retrospective study
por: Kumar Das Majumdar, Saroj, et al.
Publicado: (2020)

Nanosome-Mediated Delivery Of Protein Kinase D Inhibitor Protects Chondrocytes From Interleukin-1β-Induced Stress And Apoptotic Death
por: Cho, Hongsik, et al.
Publicado: (2019)

Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
por: Badiginchala, Revathi, et al.
Publicado: (2023)

Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer
por: Khurana, Namrata, et al.
Publicado: (2017)

Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy
por: Griffith, James, et al.
Publicado: (2017)

Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma
por: Greenberg, Jacob W., et al.
Publicado: (2021)

Successful downstaging of locally recurrent penile squamous cell carcinoma with neoadjuvant nanosomal docetaxel lipid suspension (NDLS) based regimen followed by curative surgery
por: Gupta, Sameer, et al.
Publicado: (2017)

Combination of Tipifarnib and Sunitinib Overcomes Renal Cell Carcinoma Resistance to Tyrosine Kinase Inhibitors via Tumor-Derived Exosome and T Cell Modulation
por: Greenberg, Jacob W., et al.
Publicado: (2022)

Molecular mechanisms of penile traction for penile rehabilitation in a bilateral cavernous nerve crush injury rat model
por: Dick, Brian, et al.
Publicado: (2023)

High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer
por: Datta, Amrita, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kj2e6soriin1uaetcanu845bum